Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma

Journal of the National Cancer Institute

Volumn 91, Issue 10, 1999, Pages 854-861

  Brauch, Hiltrud ^b   Weirich, Gregor ^c   Hornauer, Maria Anna ^c   Störkel, Stefan ^a   Wöhl, Thorsten ^c   Brüning, Thomas ^c  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROETHYLENE;

ADULT; AGED; ARTICLE; BASE PAIRING; CLINICAL ARTICLE; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; MUTAGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DNA, NEOPLASM; ENVIRONMENTAL EXPOSURE; FEMALE; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; SOLVENTS; TRICHLOROETHYLENE;

EID: 0033583793     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Latif F, Tory K, Gnarra J, Kuzmin I, Yao M, Stackhouse T, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1990;260:1317-20.
2. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996;8:348-57.
3. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7:85-90.
4. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, et al. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 1994;3:2169-73.
5. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary renal cell carcinomas. Cancer Res 1994;54:2852-5.
6. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994;91:9700-4.
7. McLaughlin JK, Mandel JS, Blot WT, Schuman LM, Mehl ES, Fraumeni JFJr. A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst 1984;72:275-84.
8. International Agency for Research on Cancer (IARC). Drycleaning, some chlorinated solvents and other industrial chemicals. IARC monographs. Lyon (France): IARC; 1995. p. 63.
9. Henschler D, Vamvakas S, Lammert M, Dekant W, Kraus B, Thomas B, et al. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch Toxicol 1995;69:291-9.
10. Vamvakas S, Bruning T, Thomasson B, Lammert M, Baumuller A, Bolt HM, et al. Renal cell cancer correlated with occupational exposure to trichloroethene. J Cancer Res Clin Oncol 1998;124:374-82.
11. Weirich G, Hornauer MA, Bruning T, Hofler H, Brauch H. Fixed archival tissue. Purify DNA and primers for good PCR yield! Mol Biotechnol 1997; 8:299-301.
12. Glavac D, Neumann HP, Wittke C, Jaenig H, Masek O, Streicher T, et al. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 1996;98:271-80.
13. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H, el al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995;95: 551-6.
14. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary (NC): SAS Institute Inc.; 1995. p. 499.
15. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427-8.
16. Bressac B, Kew M, Wands J, Ozturk M, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350: 429-31.
17. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327: 721-4.
18. Teh BT, Giraud S, Sari NF, Hii SI, Bergerat JP, Larsson C, et al. Familial non-VHL non-papillary clear-cell renal cancer [letter]. Lancet 1997;349: 848-9.
19. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch Toxicol 1997;71:332-5.
20. McLaughlin JK, Blot WJ. A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int Arch Occup Environ Health 1997;70:222-31.
21. Knudson AG Jr. Genetics of human cancer. Annu Rev Genet 1986;20: 231-51.
22. Duncan BK, Miller JH. Mutagenic deamination of cytosine residues in DNA. Nature 1990;287:560-1.
23. Inga A, Iannone R, Monti P, Molina F, Bolognesi M, Abbondandolo A, et al. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene 1997; 14:1307-13.
24. Kuzmin I, Duh FM, Latif F, Geil L, Zbar B, Lerman MI. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 1995;10:2185-94.
25. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, et al. Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma [published erratum appears in Am J Hum Genet 1995;56:356]. Am J Hum Genet 1994;55:1092-102.
26. Kenck C, Wilhelm M, Bugert P, Staehler G, Kovacs G. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J Pathol 1996;179:157-61.
27. Davidson IW, Beliles RP. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev 1991;23:493-599.
28. National Toxicology Program. Toxicology and carcinogenesis studies of trichloroethylene in four strains of rats (ACI, August, Marshall, Osborne-Mendel) (gavage studies). National Toxicology Program 1988; TR-273. Bethesda (MD): National Institutes of Health, Department of Health and Human Services; 1988.
29. National Toxicology Program. Carcinogenesis studies of trichloroethylene (without epichlorohydrin) in F344/N rats and B6C3F1 mice (gavage studies). National Toxicology Program 1990; TR-243. Bethesda (MD): National Institutes of Health, Department of Health and Human Services; 1990.
30. Goeptar AR, Commandeur JN, van Ommen B, van Bladeren PJ, Vermeulen NP. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic pathway. Chem Res Toxicol 1995;8:3-21.
31. Dekant W, Koob M, Henschler D. Metabolism of trichloroethene - in vivo and in vitro evidence for activation by glutathione conjugation. Chem Biol Interact 1990;73:89-101.
32. Dekant W, Metzler M, Henschler D. Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. Biochem Pharmacol 1986;35:2455-8.
33. Dekant W, Urban G, Gorsman C, Anders MW. Thioketene formation from α-haloalkenyl 2-nitrophenyl disulfides: models for biological reactive intermediates of cytotoxic S-conjugates. J Am Chem Soc 1991;113:5120-2.
34. Bernauer U, Birner G, Dekant W, Henschler D. Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch Toxicol 1996; 70:338-46.
35. Bruning T, Vamvakas S, Makropoulos V, Birner G. Acute intoxication with trichloroethene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol Sci 1998;41:157-65.
36. Dekant W, Vamvakas S, Berthold K, Schmidt S, Wild D, Henschler D. Bacterial beta-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene. Chem Biol Interact 1986;15: 31-45.
37. Vamvakas S, Dekant W, Berthold K, Schmidt S, Wild D, Henschler D. Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. Biochem Pharmacol 1987; 36:2741-8.
38. Commandeur JN, Boogaard PJ, Mulder GJ, Vermeulen NP. Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene. Arch Toxicol 1991;65:373-80.
39. Muller M, Birner G, Sander M, Dekant W. Reactivity of haloketenes and halothioketenes with nucleobases: reactions in vitro with DNA. Chem Res Toxicol 1998;11:464-70.
40. Muller M, Birner G, Dekant W. Reactivity of haloketenes and halothioketenes with nucleobases: chemical characterization of reaction products. Chem Res Toxicol 1998;11:454-63.
41. Richter H, Vamvakas S. S-(1,2-dichlorovinyl)-L-cysteine-induced dedifferentiation and p53 gene mutations in LLC-PK1 cell: a comparative investigation with S-(2-chloroethyl)cysteine, potassium bromate, cis-platinum and styrene oxide. Toxicol Lett 1998;94:145-57.
42. Volkel W, Dekant W. Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate ß-lyase-mediated cleavage of the trichloroethylene metabolite S-(1,2-Dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem Res Toxicol 1998;11:1082-8.
43. Hollstein M, Marion MJ, Lehman T, Welsh J, Harris CC, Martel-Planche G, et al. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 1994;15:1-3.